Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Rahul Aggarwal (ucsf)
Headshot of Rahul Aggarwal
Rahul Aggarwal

Description

Summary

Official Title

A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-969 in Adult Subjects With Metastatic Castration-Resistant Prostate Cancer

Keywords

Metastatic Castration-Resistant Prostate Cancer, mCRPC, ABBV-969, Prostatic Neoplasms

Eligibility

Locations

  • Univ California, San Francisco /ID# 261715 accepting new patients
    San Francisco California 94143-2204 United States
  • City of Hope /ID# 262059 accepting new patients
    Duarte California 91010 United States

Lead Scientist at University of California Health

  • Rahul Aggarwal (ucsf)
    I am a Medical Oncologist within the Division of Hematology/Oncology at the University of California San Francisco. My clinical practice focuses on patients with advanced solid tumor malignancies with a particular emphasis on genitourinary malignancies including prostate, kidney, bladder, and testicular cancer.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
AbbVie
Links
Related Info
ID
NCT06318273
Phase
Phase 1 research study
Study Type
Interventional
Participants
Expecting 140 study participants
Last Updated